2,4,6-Trimethyl-1,3,5-trithiane
Common Name: |
2,4,6-Trimethyl-1,3,5-trithiane |
IUPAC Name: |
2,4,6-trimethyl-1,3,5-trithiane |
Molecular Formula: |
C6H12S3 |
SMILES: |
CC1SC(SC(S1)C)C |
Inchi: |
1S/C6H12S3/c1-4-7-5(2)9-6(3)8-4/h4-6H,1-3H3 |
Inchi Key: |
XQVYLDFSPBXACS-UHFFFAOYSA-N |
Cas No: |
23769-39-3 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
180.35 |
Mass (g/mol) |
180.01 |
Molar Refractivity |
51.62 |
Net Charge |
|
HBD |
|
HBA |
0 |
Rt Bonds |
0 |
Rings |
1 |
TPSA |
75.90 |
Hetero Atoms |
3 |
Heavy Atoms |
9 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
100.00 to 102.00 |
Boiling Point (°C@760.00mm Hg) |
245.00 to 247.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.04 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
1.00 |
LogP |
3.238 |
iLOGP |
2.23 |
XLOGP3 |
3.54 |
WLOGP |
3.24 |
MLOGP |
2.21 |
ESOL Log S |
-3.19 |
ESOL Solubility (mg/ml) |
0.117 |
ESOL Solubility (mol/l) |
0.001 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-4.82 |
Ali Solubility (mg/ml) |
0 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-1.51 |
Silicos-IT Solubility (mg/ml) |
5.56 |
Silicos-IT Solubility (mol/l) |
0.03 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.89 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.552 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.853 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |